Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer

Published:2020-01-13 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Vasconcellos Vitor F¹,Marta Guilherme N¹,da Silva Edina MK²,Gois Aecio FT³,de Castria Tiago B¹,Riera Rachel³

Affiliation:

1. Instituto do Câncer do Estado de São Paulo (ICESP/FMUSP); Medical Oncology; Av. Dr Arnaldo 251 São Paulo Sao Paulo Brazil 01246-000

2. Universidade Federal de São Paulo; Emergency Medicine and Evidence Based Medicine; Rua Borges Lagoa 564 cj 64 Vl. Clementino São Paulo São Paulo Brazil 04038-000

3. Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde; Cochrane Brazil; Rua Pedro de Toledo, 598 São Paulo São Paulo Brazil 04039-001

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009256.pub3/epdf/full

Reference51 articles.

1. Comparison of efficacy and toxicity between gemcitabine plus carboplatin and gemcitabine plus cisplatin in the treatment of advanced non-small cell lung cancer;Cai;Zhongguo Fei Ai Za Zhi,2002

2. A phase II randomized study of paclitaxel plus carboplatin or cisplatin against chemo-naive inoperable non-small cell lung cancer in the elderly;Chen;Journal of Thoracic Oncology,2006

3. Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: results from a British Thoracic Oncology Group randomised phase III trial;Ferry;European Journal of Cancer,2017

4. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group;Fossella;Journal of Clinical Oncology,2003

5. Randomized, multicenter, phase II study of gemcitabine plus cisplatin versus gemcitabine plus carboplatin in patients with advanced non-small cell lung cancer;Mazzanti;Lung Cancer,2003

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin Resistance in Cancer Therapy: Causes and Overcoming Strategies;ChemistrySelect;2024-06-26

2. Modulation of the Effect of Cisplatin on Nicotine-Stimulated A549 Lung Cancer Cells Using Analog of Marine Sponge Toxin Loaded in Gelatin Nanoparticles;Nanomaterials;2024-04-30

3. Attenuation of Nicotine Effects on A549 Lung Cancer Cells by Synthetic α7 nAChR Antagonists APS7-2 and APS8-2;Marine Drugs;2024-03-26

4. Development, optimization and characterization of cisplatin loaded cubosomes for human lung carcinoma;Drug Development and Industrial Pharmacy;2024-03-20

5. Association between the modified lung immune predictive index and clinical outcomes of advanced non-small cell lung cancer treated with first-line immune checkpoint inhibitors combined with chemotherapy;Journal of Thoracic Disease;2023-11